Need an original paper?
Buy Essay Now
Research Database of Quotes
It is sometimes difficult to be inspired when trying to write a persuasive essay, book report or thoughtful research paper. Often of times, it is hard to find words that best describe your ideas. Paper-Research now provides a database of over 150,000 quotations and proverbs from the famous inventors, philosophers, sportsmen, artists, celebrities, business people, and authors that are aimed to enrich and strengthen your essay, term paper, book report, thesis or research paper.
Try our free search of constantly updated quotations and proverbs database.
Browse Authors
(Click a letter to view the authors)
Ned Riley Quotes
«One of the pockets of strength has been in the health care area. You could flip a coin on the Nasdaq -- it's been a very tepid and guarded rally in the Nasdaq . But I think the Dow gains will prevail.»
Author: Ned Riley
«There wasn't enough in my judgment to alleviate the fears that we are in the throes of a lack of confidence in the market.»
Author: Ned Riley
«patience, knowledge and a lot of research.»
Author: Ned Riley
«The big news is clearly the payroll report.»
Author: Ned Riley
«I think there's little room for mistakes.»
Author: Ned Riley
«I would be very surprised to see a beneficial report.»
Author: Ned Riley
«You had to be in tech to win in this period.»
Author: Ned Riley
«I believe the group is going to be able to grow at least 8 to 10 percent in the future and I think the S&P earnings are going to slow down to maybe 7 or 8 percent, ... So this group could have actually a premium growth rate and yet a discount to the market that's, at least, 50 percent, if not lower.»
Author: Ned Riley
«This is an opportunity, ... You can find some health care stocks with price- earnings ratios, ironically, more cheap than they are in the cyclical area. The health care group of stocks that I like sell about 28 times earnings and have growth rates of 14 percent.»
Author: Ned Riley
«This company was maintaining a 60 (price-to-earnings ratio) and that was excessive, relative to its growth rate, ... Now, it's more reasonably priced. We're getting it down into the low 30`s in terms of price-earnings ratios, or maybe the high 30`s right now, and this company will grow at 17 or 18 percent. So Pfizer looks good, at this point.»
Author: Ned Riley